Clinical Trial

Neuromodulation and fMRI in Neurodegenerative Diseases Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
In addition to neuronal loss, dysfunction in brain network connectivity has been identified as a correlate of cognitive deficits in neurodegenerative and post-traumatic brain injury states. Transcranial alternating current stimulation (tACS) has been suggested as a promising, non-invasive, method of normalizing network connectivity and hence improving cognition, notably memory. This study will examine the efficacy of tACS at improving working memory performance in patients with neurodegeneration and its correlation to changes in network connectivity, based on functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) imaging data.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-07.
Trial Details
NCT Number NCT06873750
Lead Sponsor Sunnybrook Health Sciences Centre
Conditions Mild Cognitive Impairment, Traumatic Brain Injury, Neurodegeneration
Enrollment 30 participants
Start Date 2026-06-01
Primary Completion 2028-09-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-01